{"id":"gdmt","rwe":[{"pmid":"41906611","year":"2026","title":"Heart Failure Therapy Improves Outcomes in Adults With Congenital Heart Disease and Left Ventricular Dysfunction.","finding":"","journal":"JACC. Advances","studyType":"Clinical Study"},{"pmid":"41904956","year":"2026","title":"Heart failure outcomes in a virtually run hospital-at-home setting.","finding":"","journal":"European heart journal. Quality of care & clinical outcomes","studyType":"Clinical Study"},{"pmid":"41903581","year":"2026","title":"Guideline-directed medical therapy and hypotension after initiation of Vericiguat: Insights from the VERIFY-HF study.","finding":"","journal":"Journal of cardiology","studyType":"Clinical Study"},{"pmid":"41899053","year":"2026","title":"Two-Year Implementation, Adherence, and Outcomes of Quadruple Guideline-Directed Medical Therapy in Newly Diagnosed HFrEF: Insights from the Prospective CaRD Registry.","finding":"","journal":"Journal of clinical medicine","studyType":"Clinical Study"},{"pmid":"41891318","year":"2026","title":"Standardizing the Clinical Approach to Cancer Therapy-Related Cardiac Dysfunction: Applying Cardio-Oncology Guidelines as a Practical Tool for Hematology and Oncology Providers.","finding":"","journal":"Cancer medicine","studyType":"Clinical Study"}],"tags":[{"label":"Small Molecule","category":"modality"},{"label":"Active","category":"status"},{"label":"Fu Wai Hospital, Beijing, China","category":"company"}],"phase":"marketed","safety":{},"trials":[],"aliases":["Conventional treatment","Guideline-directed medical therapy"],"company":"Fu Wai Hospital, Beijing, China","patents":[],"pricing":[],"_sources":{"trials":{"url":"https://clinicaltrials.gov/search?intr=GDMT","method":"api_direct","source":"ClinicalTrials.gov","rawText":"","confidence":1,"sourceType":"ctgov","retrievedAt":"2026-04-20T00:57:33.753946+00:00"},"regulatory.ca":{"url":"","method":"api_direct","source":"Health Canada DPD","rawText":"","confidence":1,"sourceType":"health_canada_dpd","retrievedAt":"2026-04-20T00:57:39.113982+00:00"},"publicationCount":{"url":"https://pubmed.ncbi.nlm.nih.gov/?term=GDMT","method":"api_direct","source":"PubMed/NCBI","rawText":"","confidence":1,"sourceType":"pubmed","retrievedAt":"2026-04-20T00:57:39.412809+00:00"}},"allNames":["gdmt"],"offLabel":[],"synonyms":[],"timeline":[],"approvals":[],"ecosystem":[],"mechanism":{"modality":"Small Molecule","explanation":"","oneSentence":"","technicalDetail":"gdmt is a small molecule that modulates the activity of a specific protein or receptor, leading to changes in cellular signaling pathways and ultimately resulting in a therapeutic effect."},"commercial":{},"references":[{"id":1,"url":"https://clinicaltrials.gov/search?intr=gdmt","fields":["trials"],"source":"ClinicalTrials.gov"},{"id":2,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=gdmt","fields":["publications"],"source":"PubMed/NCBI"}],"_enrichedAt":"2026-03-31T10:19:47.831863","_validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T00:57:41.419365+00:00","fieldsConflicting":1,"overallConfidence":0.8},"biosimilars":[],"competitors":[],"genericName":"gdmt","indications":{"approved":[],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"relatedDrugs":[],"trialDetails":[{"nctId":"NCT07295522","phase":"PHASE4","title":"Pharmacological Optimization in Prevention in Heart Failure: A Sex-gap?","status":"NOT_YET_RECRUITING","sponsor":"IRCCS Policlinico S. Donato","startDate":"2026-04-08","conditions":["Heart Failure","Acute Heart Failure","Heart Failure With Reduced Ejection Fraction (HFrEF)","Heart Failure With Preserved Ejection Fraction (HFPEF)","Heart Failure With Mildly Reduced Ejection Fraction"],"enrollment":368,"completionDate":"2028-06-08"},{"nctId":"NCT07492524","phase":"NA","title":"Telemedicine-based Integrated Management of Atrial Fibrillation and Heart Failure in Older Patients in Village Clinics","status":"NOT_YET_RECRUITING","sponsor":"Jiangsu Taizhou People's Hospital","startDate":"2026-03-25","conditions":["Atrial Fibrillation","Heart Failure"],"enrollment":1227,"completionDate":"2029-04-01"},{"nctId":"NCT07492498","phase":"NA","title":"Telemedicine-Based Integrated Care for Heart Failure Prevention in Older Patients With Atrial Fibrillation (MIRACLE-AF III)","status":"NOT_YET_RECRUITING","sponsor":"Jiangsu Taizhou People's Hospital","startDate":"2026-04-01","conditions":["Atrial Fibrillation","Heart Failure"],"enrollment":1268,"completionDate":"2030-04-01"},{"nctId":"NCT05149755","phase":"NA","title":"Evolut™ EXPAND TAVR II Pivotal Trial","status":"ACTIVE_NOT_RECRUITING","sponsor":"Medtronic Cardiovascular","startDate":"2022-04-27","conditions":["Moderate Aortic Valve Stenosis"],"enrollment":650,"completionDate":"2034-12"},{"nctId":"NCT06906640","phase":"NA","title":"Implementation pRogram to Improve Screening and Management for CKD in Diabetes (IRIS-CKD) (Program 2)","status":"RECRUITING","sponsor":"Duke University","startDate":"2025-10-28","conditions":["Chronic Kidney Disease(CKD)","Type 2 DM","Type 2 Diabetes Mellitus (T2DM)"],"enrollment":420,"completionDate":"2027-04-01"},{"nctId":"NCT07214376","phase":"NA","title":"A Randomized Placebo-procedure Controlled Trial of the Enhancor System (PULmonary Artery Denervation) to Evaluate Safety and Efficacy in Patients With Combined Pre- and Post-capillary Pulmonary Hypertension Associated With Left Heart Disease","status":"NOT_YET_RECRUITING","sponsor":"Pulnovo Medical, Inc.","startDate":"2026-04-01","conditions":["Pulmonary Hypertension","Heart Failure With Reduced Ejection Fraction","Hypertension","Vascular Diseases","Cardiovascular Diseases","Heart Failure","Heart Failure With Preserved Ejection Fraction","Heart Failure With Mid Range Ejection Fraction"],"enrollment":750,"completionDate":"2031-12-31"},{"nctId":"NCT02627196","phase":"NA","title":"Baroreflex Activation Therapy for Heart Failure","status":"COMPLETED","sponsor":"CVRx, Inc.","startDate":"2016-04-19","conditions":["Heart Failure"],"enrollment":1090,"completionDate":"2023-10"},{"nctId":"NCT06965504","phase":"NA","title":"INitiation and Titration of Guideline Directed Medical TheRApy in HearT Failure Cardiogenic Shock With ImpElla 5.5 for Cardiac Recovery","status":"NOT_YET_RECRUITING","sponsor":"Abiomed Inc.","startDate":"2026-04-01","conditions":["Heart Failure","Cardiogenic Shock","Reduced Ejection Fraction Heart Failure"],"enrollment":60,"completionDate":"2029-06-01"},{"nctId":"NCT07434791","phase":"NA","title":"Goal-Directed Therapy to Reduce Kidney and Cardiovascular Risk in Diabetic Kidney Disease (GOLD-STANDARD)","status":"NOT_YET_RECRUITING","sponsor":"Sunnybrook Health Sciences Centre","startDate":"2026-03","conditions":["Diabetic Kidney Disease (DKD)"],"enrollment":100,"completionDate":"2029-03"},{"nctId":"NCT07433504","phase":"NA","title":"A Prospective, Multicenter, Randomized Controlled Clinical Trial of Transcatheter Tricuspid Valve Clipping Systems.","status":"RECRUITING","sponsor":"Shanghai Huihe Medical Technology Co., Ltd","startDate":"2026-01-28","conditions":["Severe or Greater Tricuspid Regurgitation"],"enrollment":132,"completionDate":"2031-12-31"},{"nctId":"NCT07430930","phase":"NA","title":"Pragmatic Trial of Messaging to Providers About Treatment of Chronic Kidney Disease","status":"NOT_YET_RECRUITING","sponsor":"Yale University","startDate":"2026-03","conditions":["Chronic Kidney Diseases"],"enrollment":1000,"completionDate":"2028-03"},{"nctId":"NCT06128980","phase":"PHASE2,PHASE3","title":"Withdrawal of Treatment for Heart Failure Patients With Recovery From Tachycardia-induced Cardiomyopathy","status":"RECRUITING","sponsor":"Herlev and Gentofte Hospital","startDate":"2025-01-09","conditions":["Heart Failure With Reduced Ejection Fraction","Heart Rhythm Disorder"],"enrollment":348,"completionDate":"2032-01"},{"nctId":"NCT06813820","phase":"NA","title":"RELIVE (Randomized Evaluation of Less Invasive Ventricular Enhancement) Trial","status":"RECRUITING","sponsor":"BioVentrix","startDate":"2025-09-29","conditions":["Left Ventricle Remodeling","Left Ventricle Dilated","CHF"],"enrollment":135,"completionDate":"2032-08"},{"nctId":"NCT06675552","phase":"","title":"Non-interventional Study on Guideline Directed Medical Therapy for Patients With Heart Failure (HF) in Germany","status":"RECRUITING","sponsor":"AstraZeneca","startDate":"2024-11-15","conditions":["Heart Disease","Heart Failure","Cardiovascular Disease","Heart Failure, Systolic"],"enrollment":438,"completionDate":"2027-06-30"},{"nctId":"NCT07252310","phase":"PHASE4","title":"Pilot Study of StudyU for N-of-1 Trials in HFrEF Patients (N-of-1 App)","status":"ENROLLING_BY_INVITATION","sponsor":"Weill Medical College of Cornell University","startDate":"2026-02-10","conditions":["HFrEF - Heart Failure With Reduced Ejection Fraction","Heart Failure","Heart Failure, Systolic","Heart Diseases"],"enrollment":5,"completionDate":"2027-08"},{"nctId":"NCT07391683","phase":"NA","title":"Telemedically Assisted Optimization for Heart Failure Patients Before Cardiac Surgery to Improve Perioperative Outcome","status":"RECRUITING","sponsor":"Medical University Innsbruck","startDate":"2026-02-16","conditions":["Patients With Heart Failure Undergoing Cardiac Surgery"],"enrollment":162,"completionDate":"2034-01-01"},{"nctId":"NCT06526195","phase":"NA","title":"Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure","status":"RECRUITING","sponsor":"Abbott Medical Devices","startDate":"2024-12-13","conditions":["Heart Failure","Heart Diseases","Cardiovascular Diseases","Pulmonary Hypertension"],"enrollment":850,"completionDate":"2032-09"},{"nctId":"NCT07412626","phase":"NA","title":"Evaluation of the HeartLogic Diagnostic in Optimizing Guideline-directed Medical Therapy in Patients With Congestive Heart Failure and Chronically Low Ejection Fractions (EFs)","status":"NOT_YET_RECRUITING","sponsor":"Robert Pickett","startDate":"2026-04-01","conditions":["Congestive Heart Failure Chronic","Low Ejection Fraction"],"enrollment":135,"completionDate":"2028-03"},{"nctId":"NCT07411287","phase":"NA","title":"Gut Microbiota Modulation With Synbiotics After Acute Coronary Syndrome","status":"NOT_YET_RECRUITING","sponsor":"Centre Hospitalier de Bienne","startDate":"2026-06-01","conditions":["Atheroscleroses, Coronary","Microbiota"],"enrollment":80,"completionDate":"2028-05-31"},{"nctId":"NCT07405944","phase":"PHASE4","title":"Vericiguat and Reverse Remodeling Indices in Heart Failure","status":"RECRUITING","sponsor":"University Medical Centre Ljubljana","startDate":"2025-11-01","conditions":["Heart Failure With Reduced Ejection Fraction (HFrEF)","Chronic Heart Failure"],"enrollment":60,"completionDate":"2027-12-31"},{"nctId":"NCT06818084","phase":"PHASE4","title":"TRanscAtheter TreatMent of PurE Aortic Regurgitation With VitaFlow Liberty System","status":"RECRUITING","sponsor":"Ruijin Hospital","startDate":"2025-04-29","conditions":["AORTIC VALVE DISEASES","Aortic Regurgitation","Transcatheter Aortic Valve Replacement (TAVR)"],"enrollment":120,"completionDate":"2027-11-30"},{"nctId":"NCT07349979","phase":"NA","title":"PCI With Guideline-Directed Medical Therapy for HFpEF Patients With Ischemic Cardiomyopathy","status":"NOT_YET_RECRUITING","sponsor":"Nanjing First Hospital, Nanjing Medical University","startDate":"2026-01-30","conditions":["Heart Failure With Reduced Ejection Fraction","Coronary Artery Disease"],"enrollment":654,"completionDate":"2028-01-30"},{"nctId":"NCT07349875","phase":"PHASE4","title":"Colchicine Treatment for Non-Flow-Limiting Coronary Plaque by Coronary CTA: A Randomized Controlled Trial","status":"RECRUITING","sponsor":"Nanjing First Hospital, Nanjing Medical University","startDate":"2026-01-01","conditions":["Coronary Artery Disease (CAD)"],"enrollment":3826,"completionDate":"2030-06-30"},{"nctId":"NCT07352891","phase":"NA","title":"Digital Remote Management for Care and Continuous Optimization Versus Usual Care to Improve Prognosis in Patients With Heart Failure With Reduced Ejection Fraction","status":"NOT_YET_RECRUITING","sponsor":"Chang sheng Ma","startDate":"2026-01","conditions":["Heart Failure With Reduced Ejection Fraction"],"enrollment":774,"completionDate":"2027-07"},{"nctId":"NCT07349888","phase":"NA","title":"Combined Mitral and Tricuspid Versus Isolated Mitral Transcatheter Edge-to-Edge Repair for Mitral Regurgitation With Tricuspid Regurgitation (DUAL-TEER Trial)","status":"NOT_YET_RECRUITING","sponsor":"Nanjing First Hospital, Nanjing Medical University","startDate":"2026-02-01","conditions":["Mitral Regurgitation","Tricuspid Regurgitation"],"enrollment":404,"completionDate":"2031-08-31"},{"nctId":"NCT07107971","phase":"NA","title":"Drug-Eluting Balloon Treatment vs. Guideline-Directed Medical Therapy for the Treatment of Lipid-Rich Plaques","status":"RECRUITING","sponsor":"Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)","startDate":"2025-11-04","conditions":["Coronary Artery Disease","Atheroscleroses","Cardiovascular Disease","Vulnerable Coronary Plaques","Vulnerable Plaque","Lipid-Rich Atherosclerosis of Coronary Artery","Acute Coronary Syndromes (ACS)"],"enrollment":400,"completionDate":"2033-01"},{"nctId":"NCT07337577","phase":"NA","title":"Large Language Model-Generated Messages to Improve Guideline-Directed Medical Therapy in Heart Failure","status":"NOT_YET_RECRUITING","sponsor":"Brigham and Women's Hospital","startDate":"2026-03-01","conditions":["Heart Failure"],"enrollment":500,"completionDate":"2027-09-01"},{"nctId":"NCT07332494","phase":"NA","title":"Digital Remote Management for Care and Continuous Optimization Versus Usual Care in Patients With Coronary Heart Disease (DigiCare-CHD)","status":"NOT_YET_RECRUITING","sponsor":"Beijing Anzhen Hospital","startDate":"2026-01","conditions":["Coronary Heart Disease","Percutaneous Coronary Intervention"],"enrollment":792,"completionDate":"2027-07"},{"nctId":"NCT07331220","phase":"NA","title":"Pulmonary Artery Denervation for Heart Failure With Preserved Left Ventricular Ejection Fraction","status":"NOT_YET_RECRUITING","sponsor":"Nanjing First Hospital, Nanjing Medical University","startDate":"2025-12-30","conditions":["Heart Failure With Preserved Ejection Fraction"],"enrollment":310,"completionDate":"2028-12-30"},{"nctId":"NCT06029712","phase":"PHASE2","title":"Heart Failure Polypill at a Safety Net Hospital","status":"COMPLETED","sponsor":"University of California, San Francisco","startDate":"2024-02-27","conditions":["Heart Failure With Reduced Ejection Fraction","HIV Infections"],"enrollment":35,"completionDate":"2025-01-29"},{"nctId":"NCT05831085","phase":"NA","title":"Diabetes-Centered Evaluation of Revascularization Strategy of Functional and Imaging-CombiNEd State-of-the-Art Percutaneous Coronary Intervention or Coronary-Artery Bypass Grafting in Patients With Diabetes Mellitus and Multivessel Coronary Artery Disease","status":"RECRUITING","sponsor":"Duk-Woo Park, MD","startDate":"2024-06-14","conditions":["Coronary Artery Stenosis"],"enrollment":1500,"completionDate":"2027-12"},{"nctId":"NCT07009418","phase":"NA","title":"Smart Angioplasty Research Team-Coronary CT Angiography Versus Standard Care as Follow-up Strategies in High-Risk Patients After PCI (SMART-CARE)","status":"RECRUITING","sponsor":"Samsung Medical Center","startDate":"2025-10-02","conditions":["Ischemic Heart Disease","Coronary Artery Disease"],"enrollment":3500,"completionDate":"2032-12-31"},{"nctId":"NCT06641921","phase":"NA","title":"Strategy TO Prevent Decompensated Heart Failure","status":"COMPLETED","sponsor":"Seerlinq s. r. o.","startDate":"2024-05-01","conditions":["Heart Failure","Remote Monitoring"],"enrollment":330,"completionDate":"2025-11-01"},{"nctId":"NCT04331769","phase":"NA","title":"Clinical Evaluation of the AccuCinch® Ventricular Restoration System in Patients Who Present With Symptomatic Heart Failure With Reduced Ejection Fraction (HFrEF): The CORCINCH-HF Study","status":"RECRUITING","sponsor":"Ancora Heart, Inc.","startDate":"2020-12-21","conditions":["Heart Failure With Reduced Ejection Fraction (HFrEF)","Dilated Cardiomyopathy"],"enrollment":400,"completionDate":"2030-12-21"},{"nctId":"NCT06103565","phase":"NA","title":"EHR Nudges to Improve Quality of Care in HF","status":"COMPLETED","sponsor":"Northwestern University","startDate":"2025-05-13","conditions":["Heart Failure With Reduced Ejection Fraction"],"enrollment":3,"completionDate":"2025-08-13"},{"nctId":"NCT04633005","phase":"PHASE2","title":"Polypill Strategy for Heart Failure With Reduced Ejection Fraction","status":"COMPLETED","sponsor":"University of Texas Southwestern Medical Center","startDate":"2021-11-15","conditions":["Heart Failure"],"enrollment":212,"completionDate":"2025-10-31"},{"nctId":"NCT07230756","phase":"","title":"Coronary Heart Disease Complicated With Ischemic Mitral Regurgitation in China","status":"NOT_YET_RECRUITING","sponsor":"China National Center for Cardiovascular Diseases","startDate":"2025-11-10","conditions":["Ischemic Mitral Regurgitation","Coronary Heart Disease (CHD)"],"enrollment":6000,"completionDate":"2029-12-31"},{"nctId":"NCT05534932","phase":"NA","title":"Guideline-directed Management and Therapy (GDMT) for the Prevention of Postpartum Cardiac Dysfunction in Preeclamptic African American Women","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Chicago","startDate":"2022-10-27","conditions":["Preeclampsia Postpartum"],"enrollment":20,"completionDate":"2026-11-01"},{"nctId":"NCT07217106","phase":"","title":"A Study of Accelerated Guideline-Directed Medical Therapy for Heart Failure","status":"COMPLETED","sponsor":"Novartis Pharmaceuticals","startDate":"2024-03-03","conditions":["Heart Failure"],"enrollment":342,"completionDate":"2024-07-01"},{"nctId":"NCT07023666","phase":"PHASE2","title":"Early Screening and Treatment of Heart Complication in Sickle Cell Disease","status":"RECRUITING","sponsor":"Inova Health Care Services","startDate":"2025-10-07","conditions":["Sickle Cell Disease"],"enrollment":100,"completionDate":"2027-06-30"},{"nctId":"NCT07211724","phase":"NA","title":"Methamphetamine Use Disorder Support in Heart Failure Pilot Study","status":"NOT_YET_RECRUITING","sponsor":"University of Southern California","startDate":"2025-11-01","conditions":["Heart Failure","Methamphetamine Use Disorder"],"enrollment":50,"completionDate":"2026-07-31"},{"nctId":"NCT07197021","phase":"EARLY_PHASE1","title":"Transcatheter Edge-to-Edge Repair In Moderate and Exertional-Induced Severe MR (TIMER)","status":"NOT_YET_RECRUITING","sponsor":"Sun Yat-sen University","startDate":"2025-10-01","conditions":["Mitral Regurgitation Functional"],"enrollment":300,"completionDate":"2030-09-30"},{"nctId":"NCT06300086","phase":"NA","title":"Nationwide Utilization of Danish Government Electronic Letter System for Increasing Guideline-directed Medical Therapy in Chronic Kidney Disease","status":"COMPLETED","sponsor":"Tor Biering-Sørensen","startDate":"2024-08-19","conditions":["Chronic Kidney Diseases","Behavior and Behavior Mechanisms"],"enrollment":28388,"completionDate":"2025-02-19"},{"nctId":"NCT06700213","phase":"","title":"Guideline Directed Medical Therapy in Patients With Heart Failure","status":"COMPLETED","sponsor":"Massachusetts General Hospital","startDate":"2023-09-22","conditions":["Heart Failure"],"enrollment":300,"completionDate":"2025-09-22"},{"nctId":"NCT05180773","phase":"PHASE4","title":"Impact of Bromocriptine on Clinical Outcomes for Peripartum Cardiomyopathy","status":"RECRUITING","sponsor":"Dennis M. McNamara, MD, MS","startDate":"2022-07-27","conditions":["Peripartum Cardiomyopathy, Postpartum"],"enrollment":250,"completionDate":"2028-12-31"},{"nctId":"NCT05990296","phase":"NA","title":"Evaluating Strategies to Improve Guideline Directed Medical Therapy: The GDMT Research, Education & Assist Trial for Heart Failure Care","status":"COMPLETED","sponsor":"Geisinger Clinic","startDate":"2023-08-01","conditions":["Heart Failure","Heart Failure With Reduced Ejection Fraction"],"enrollment":4306,"completionDate":"2025-05-17"},{"nctId":"NCT06868797","phase":"NA","title":"Acute Reno-Cardiac Action of Dapagliflozin In Advanced Heart Failure Patients on Heart Transplant Waiting List","status":"RECRUITING","sponsor":"Central Hospital, Nancy, France","startDate":"2025-08-29","conditions":["Heart Failure"],"enrollment":103,"completionDate":"2027-09-12"},{"nctId":"NCT06416813","phase":"NA","title":"Preventive Intervention Value of DCB in Vulnerable Coronary Atherosclerotic Plaques","status":"ACTIVE_NOT_RECRUITING","sponsor":"Yong He","startDate":"2025-06-06","conditions":["Acute Coronary Syndrome"],"enrollment":140,"completionDate":"2027-12-01"},{"nctId":"NCT06552637","phase":"NA","title":"Synchronized Diaphragmatic Stimulation in Symptomatic Heart Failure","status":"NOT_YET_RECRUITING","sponsor":"VisCardia Inc.","startDate":"2025-10-15","conditions":["Heart Failure With Reduced Ejection Fraction"],"enrollment":270,"completionDate":"2027-12"},{"nctId":"NCT07154758","phase":"NA","title":"Registry BAsed Optimization Of Therapy in Heart Failure","status":"RECRUITING","sponsor":"Region Stockholm","startDate":"2024-05-01","conditions":["Heart Failure"],"enrollment":1000,"completionDate":"2026-06-30"},{"nctId":"NCT05433220","phase":"NA","title":"PRagmatic Trial Of Messaging to Providers About Treatment of Heart Failure at Inova","status":"RECRUITING","sponsor":"Inova Health Care Services","startDate":"2022-08-25","conditions":["Heart Failure"],"enrollment":5000,"completionDate":"2026-08"},{"nctId":"NCT07130175","phase":"NA","title":"Radiofrequency Ablation for Polymorphic Ventricular Tachycardia With Heart Failure (RFCA for PMVT-HF)","status":"COMPLETED","sponsor":"Qian Feng","startDate":"2022-12-31","conditions":["Polymorphic Ventricular Tachycardia","Heart Failure"],"enrollment":118,"completionDate":"2024-12-31"},{"nctId":"NCT06433687","phase":"","title":"Evaluation of the HekaHeart Platform in Medication Management for Heart Failure Patients","status":"WITHDRAWN","sponsor":"Yale University","startDate":"2025-10","conditions":["Heart Failure With Reduced Ejection Fraction"],"enrollment":0,"completionDate":"2026-10"},{"nctId":"NCT06386042","phase":"","title":"Guideline Implementation and Quality of Care in Patients With Heart Failure: the TITRATE-HF Registry","status":"ACTIVE_NOT_RECRUITING","sponsor":"Erasmus Medical Center","startDate":"2022-06-05","conditions":["Heart Failure"],"enrollment":4289,"completionDate":"2029-04"},{"nctId":"NCT01471834","phase":"NA","title":"Verification of the Efficacy and Safety of the BAROSTIM NEO System in the Treatment of Drug Resistant Hypertension","status":"ACTIVE_NOT_RECRUITING","sponsor":"CVRx, Inc.","startDate":"2011-06","conditions":["High Blood Pressure"],"enrollment":40,"completionDate":"2026-08"},{"nctId":"NCT06580392","phase":"","title":"CCM and Implementation of Guideline-Directed Medical Therapy in Patients With Heart Failure (Fix-GDMT-HF)","status":"RECRUITING","sponsor":"Impulse Dynamics","startDate":"2025-02-01","conditions":["Heart Failure"],"enrollment":200,"completionDate":"2027-12"},{"nctId":"NCT06566183","phase":"PHASE3","title":"International Study of Comparative Health Effectiveness With Medical and Invasive Approaches-Left Ventricular Dysfunction Trial","status":"NOT_YET_RECRUITING","sponsor":"NYU Langone Health","startDate":"2026-12","conditions":["Coronary Artery Disease","Cognitive Impairment","Heart Failure"],"enrollment":1200,"completionDate":"2032-12"},{"nctId":"NCT06241430","phase":"NA","title":"The CardioClip Study","status":"RECRUITING","sponsor":"Columbia University","startDate":"2024-12-18","conditions":["Heart Failure With Reduced Ejection Fraction","Mitral Regurgitation"],"enrollment":60,"completionDate":"2027-11"},{"nctId":"NCT06526988","phase":"NA","title":"Implementation and Interaction of Clinician And Patient-facing Tools Aiming to Intensify Neurohormonal Medicines for Heart Failure","status":"RECRUITING","sponsor":"University of Colorado, Denver","startDate":"2025-03-06","conditions":["Heart Failure With Reduced Ejection Fraction"],"enrollment":2200,"completionDate":"2028-09-01"},{"nctId":"NCT06702527","phase":"","title":"Optimizing Clinical Outcomes in Patients Undergoing Mitral Transcatheter Edge-to-edge Repair (M-TEER) for Severe Functional Mitral Regurgitation Towards Improved Guideline-directed Medical Therapy","status":"NOT_YET_RECRUITING","sponsor":"Institut für Pharmakologie und Präventive Medizin","startDate":"2025-06-01","conditions":["Mitral Regurgitation Functional","Heart Failure","M-TEER"],"enrollment":100,"completionDate":"2026-09-01"},{"nctId":"NCT05637853","phase":"PHASE4","title":"Telemonitored Fast Track Medical Sequencing for Heart Failure With Reduced Ejection Fraction","status":"ACTIVE_NOT_RECRUITING","sponsor":"Göteborg University","startDate":"2022-10-22","conditions":["Heart Failure With Reduced Ejection Fraction"],"enrollment":60,"completionDate":"2026-08-26"},{"nctId":"NCT06928883","phase":"NA","title":"Ticin Pilot Study: Sirolimus-Eluting Balloon for Stabilization and Regression of Non-Obstructive Coronary Plaques.","status":"NOT_YET_RECRUITING","sponsor":"Cardiocentro Ticino","startDate":"2025-04","conditions":["Coronary Arterial Disease (CAD)","Vulnerable Coronary Plaques","Multivessel Coronary Artery Disease","Coronary Vessel","Acute Coronary Syndromes (ACS)"],"enrollment":24,"completionDate":"2028-12-31"},{"nctId":"NCT03845127","phase":"NA","title":"Randomized Evaluation and Verification of Ventricular Enhancement","status":"WITHDRAWN","sponsor":"BioVentrix","startDate":"2020-01-01","conditions":["Ischemic Cardiomyopathy","Heart Failure"],"enrollment":0,"completionDate":"2024-12-31"},{"nctId":"NCT06847438","phase":"NA","title":"Tailored Electronic Intervention to Improve Therapy in a Diverse Cohort of Patients With Heart Failure","status":"RECRUITING","sponsor":"Emory University","startDate":"2025-03-24","conditions":["Heart Failure"],"enrollment":4000,"completionDate":"2026-06"},{"nctId":"NCT03016754","phase":"","title":"Heart Failure Optimization Study","status":"COMPLETED","sponsor":"Zoll Medical Corporation","startDate":"2017-03-01","conditions":["Sudden Cardiac Death","Sudden Cardiac Arrest","Heart Failure","Heart Failure Low Output"],"enrollment":602,"completionDate":"2022-06-01"},{"nctId":"NCT06641284","phase":"","title":"Gender-Based Differences in Heart Failure Hospitalizations Among Patients With Heart Failure Treated With Spironolactone","status":"COMPLETED","sponsor":"Ahmad Abdullah Salawi","startDate":"2023-10-01","conditions":["Heart Failure","Heart Failure With Reduced Ejection Fraction","Heart Failure NYHA Class II","Heart Failure NYHA Class III","Heart Failure NYHA Class IV"],"enrollment":509,"completionDate":"2024-10-15"},{"nctId":"NCT05828719","phase":"NA","title":"Revascularization Versus Medical Treatment in Patients With Ischemic Left Ventricular Dysfunction","status":"RECRUITING","sponsor":"Samsung Medical Center","startDate":"2023-06-16","conditions":["Heart Failure With Reduced Ejection Fraction","Ischemic Cardiomyopathy"],"enrollment":900,"completionDate":"2030-12-31"},{"nctId":"NCT05572957","phase":"NA","title":"LBBP as Initial Therapy in Patients With Non-ischemic Heart Failure and LBBB","status":"RECRUITING","sponsor":"The First Affiliated Hospital with Nanjing Medical University","startDate":"2022-10-14","conditions":["Non-ischemic Cardiomyopathy","Heart Failure","Left Bundle-Branch Block"],"enrollment":50,"completionDate":"2026-12"},{"nctId":"NCT06844006","phase":"NA","title":"Investigating the Impact of Nudging Cardiologists to Prescribe Guideline-directed Medical Therapy in Heart Failure Patients","status":"RECRUITING","sponsor":"Medisch Spectrum Twente","startDate":"2024-06-13","conditions":["Heart Failure"],"enrollment":1320,"completionDate":"2028-08-31"},{"nctId":"NCT04089059","phase":"NA","title":"PROACTIVE-HF IDE Trial Heart Failure NYHA Class III","status":"ACTIVE_NOT_RECRUITING","sponsor":"Endotronix, Inc.","startDate":"2020-01-10","conditions":["Heart Failure NYHA Class III"],"enrollment":738,"completionDate":"2028-04"},{"nctId":"NCT05906745","phase":"","title":"Guideline Directed Medical Therapy (GDMT) Optimization and Adherence Longitudinal Study for Heart Failure.","status":"COMPLETED","sponsor":"Tricog Health Inc","startDate":"2023-07-21","conditions":["Heart Failure"],"enrollment":52,"completionDate":"2024-09-27"},{"nctId":"NCT05792085","phase":"NA","title":"Heart Failure Optimization at Home to Improve Outcomes (Hozho): A Pragmatic Clinical Trial in Navajo Nation","status":"COMPLETED","sponsor":"University of Pennsylvania","startDate":"2023-02-01","conditions":["Heart Failure"],"enrollment":103,"completionDate":"2023-08-01"},{"nctId":"NCT05834673","phase":"NA","title":"VICTORION-ASCERTAIN: Implementation Study (v-ASCERTAIN)","status":"TERMINATED","sponsor":"Monash University","startDate":"2023-11-17","conditions":["Atherosclerotic Cardiovascular Disease (ASCVD)","Coronary Heart Disease (CHD)","Cerebrovascular Disease","Peripheral Arterial Disease (PAD)"],"enrollment":6,"completionDate":"2024-12-19"},{"nctId":"NCT04768322","phase":"NA","title":"LVAD Versus GDMT in Ambulatory Advanced Heart Failure Patients","status":"RECRUITING","sponsor":"Hospices Civils de Lyon","startDate":"2021-02-24","conditions":["End-stage Heart Failure"],"enrollment":92,"completionDate":"2029-02"},{"nctId":"NCT06742567","phase":"PHASE3","title":"Apixaban Prophylaxis for Prevention of Left Ventricular Thrombus Following Anterior Myocardial Infarction","status":"RECRUITING","sponsor":"National Institute of Cardiovascular Diseases, Pakistan","startDate":"2024-12-02","conditions":["Acute Myocardial Infarction of Anterior Wall","Left Ventricular Thrombus","Prophylaxis"],"enrollment":472,"completionDate":"2025-11-30"},{"nctId":"NCT06635863","phase":"PHASE4","title":"Comparing Immune System Suppression to Medication for Unexplained Heart Function and Irregular Heartbeat","status":"ENROLLING_BY_INVITATION","sponsor":"Roderick Tung","startDate":"2024-11-01","conditions":["Ventricular Arrythmia","Non-ischemic Cardiomyopathy","Arrhythmogenic Inflammatory Cardiomyopathy"],"enrollment":40,"completionDate":"2027-10"},{"nctId":"NCT04872959","phase":"NA","title":"TRANSFORM Heart Failure with Reduced Ejection Fraction","status":"WITHDRAWN","sponsor":"Massachusetts General Hospital","startDate":"2021-10-22","conditions":["Heart Failure, Systolic"],"enrollment":0,"completionDate":"2024-05"},{"nctId":"NCT06250257","phase":"PHASE3","title":"Bromocriptine in Dilated Cardiomyopathy Among Women of Reproductive Age","status":"RECRUITING","sponsor":"Jimma University","startDate":"2024-10-21","conditions":["Dilated Cardiomyopathy"],"enrollment":112,"completionDate":"2026-11-30"},{"nctId":"NCT06667128","phase":"NA","title":"Optimization of Heart Failure (HF) Medical Therapy After Transcatheter Valve Intervention (TVI) in Patients With Heart Failure With Reduced Ejection Fraction (HFrEF)","status":"NOT_YET_RECRUITING","sponsor":"IRCCS Ospedale San Raffaele","startDate":"2025-02-01","conditions":["Heart Failure","Valvulopathy","Aortic Stenosis","Aortic Regurgitation Disease","Mitral Regurgitation","Tricuspid Regurgitation","Brain Natriuretic Peptide","Mitraclip","TAVI(Transcatheter Aortic Valve Implantation)"],"enrollment":160,"completionDate":"2026-02-01"},{"nctId":"NCT05974189","phase":"","title":"The VERIFY Study: An Observational Study Called VERIFY to Learn More About the Use of Vericiguat in People With Chronic Heart Failure With Reduced Ejection Fraction","status":"COMPLETED","sponsor":"Bayer","startDate":"2023-07-11","conditions":["Chronic Heart Failure With Reduced Ejection Fraction"],"enrollment":1391,"completionDate":"2024-10-08"},{"nctId":"NCT05275920","phase":"NA","title":"Building Electronic Tools To Enhance and Reinforce CArdiovascular REcommendations - Heart Failure (BETTER CARE-HF)","status":"COMPLETED","sponsor":"NYU Langone Health","startDate":"2022-04-28","conditions":["Heart Failure","Heart Failure With Reduced Ejection Fraction"],"enrollment":2211,"completionDate":"2022-10-26"},{"nctId":"NCT05824923","phase":"PHASE3","title":"A Trial to Evaluate the Safety and Efficacy of Pulmonary Artery Denervation for the Treatment of Pulmonary Hypertension Associated With Left Heart Failure","status":"RECRUITING","sponsor":"Pulnovo Medical (Wuxi) Co., Ltd.","startDate":"2023-08-14","conditions":["Pulmonary Hypertension","Heart Failure With Reduced Ejection Fraction","Hypertension","Vascular Diseases","Cardiovascular Diseases","Heart Failure","Heart Failure With Preserved Ejection Fraction","Heart Failure With Mid Range Ejection Fraction"],"enrollment":264,"completionDate":"2027-02"},{"nctId":"NCT05531214","phase":"NA","title":"Creating A Cardiorenal Multidisciplinary Team for Management HF and CKD Patients","status":"COMPLETED","sponsor":"George Washington University","startDate":"2022-06-01","conditions":["Heart Failure","Chronic Kidney Diseases"],"enrollment":96,"completionDate":"2024-06-01"},{"nctId":"NCT06344910","phase":"","title":"PRagmatic Study Of Messaging to Providers of Patients With Heart Failure in Amsterdam UMC","status":"RECRUITING","sponsor":"Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)","startDate":"2024-05-21","conditions":["Heart Failure With Reduced Ejection Fraction"],"enrollment":900,"completionDate":"2025-12"},{"nctId":"NCT05799638","phase":"","title":"Strategy, Efficacy and Safety of Medication Usage in Heart Failure Patients Who Were Intolerable to GDMT","status":"COMPLETED","sponsor":"Chongqing Medical University","startDate":"2023-01-01","conditions":["Heart Failure With Reduced Ejection Fraction"],"enrollment":263,"completionDate":"2024-06-30"},{"nctId":"NCT05413447","phase":"NA","title":"Assessment of Digital Consultations on Clinical Impact and Efficiency","status":"COMPLETED","sponsor":"Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)","startDate":"2022-09-01","conditions":["Heart Failure"],"enrollment":150,"completionDate":"2024-06-06"},{"nctId":"NCT04191330","phase":"NA","title":"Artificial Intelligence Mobile Health Trial Of A Digital Platform To Optimize GDMT Using Wearable Sensors","status":"ACTIVE_NOT_RECRUITING","sponsor":"Biofourmis Inc.","startDate":"2020-01-27","conditions":["Heart Failure"],"enrollment":122,"completionDate":"2024-08-31"},{"nctId":"NCT06405555","phase":"PHASE2,PHASE3","title":"Midodrine in Heart Failure With Reduced Ejection Fraction With Hypotension","status":"NOT_YET_RECRUITING","sponsor":"Ottawa Heart Institute Research Corporation","startDate":"2024-08-01","conditions":["Heart Failure With Reduced Ejection Fraction","Hypotension","LV Dysfunction"],"enrollment":56,"completionDate":"2026-07-01"},{"nctId":"NCT05806970","phase":"NA","title":"Email Nudges to Improve GDMT (MRA) Adherence in Heart Failure","status":"WITHDRAWN","sponsor":"University of California, Los Angeles","startDate":"2023-04","conditions":["Heart Failure With Reduced Ejection Fraction"],"enrollment":0,"completionDate":"2023-07"},{"nctId":"NCT06099808","phase":"NA","title":"Veterans Affairs Pharmacist Heart Failure Medication Titration Project 1","status":"ENROLLING_BY_INVITATION","sponsor":"Stanford University","startDate":"2023-11-20","conditions":["Heart Failure"],"enrollment":110,"completionDate":"2024-09-30"},{"nctId":"NCT06068166","phase":"NA","title":"Thoracic Epidural Anesthesia Reduces Mortality and Rehospitalization for Patients With Heart Failure With Reduced Ejection Fraction","status":"COMPLETED","sponsor":"First Affiliated Hospital of Harbin Medical University","startDate":"2013-07-01","conditions":["Heart Failure With Reduced Ejection Fraction","Thoracic Epidural Anesthesia"],"enrollment":1840,"completionDate":"2023-08-31"},{"nctId":"NCT06273280","phase":"NA","title":"Renal-based Optimization of QUADruple Therapy in Patients With Heart Failure With Reduced Ejection Fraction.","status":"ACTIVE_NOT_RECRUITING","sponsor":"Ziekenhuis Oost-Limburg","startDate":"2024-02-14","conditions":["Heart Failure","Heart Failure With Reduced Ejection Fraction"],"enrollment":345,"completionDate":"2026-03"},{"nctId":"NCT06273085","phase":"NA","title":"Intensive Education Versus Usual Education of Patients for Improving Guideline Directed Medical Therapy (GDMT) Prescription in Heart Failure With Reduced Ejection Fraction","status":"UNKNOWN","sponsor":"Medstar Health Baltimore","startDate":"2024-02-01","conditions":["Heart Failure","Patient Acceptance of Health Care"],"enrollment":500,"completionDate":"2025-02"},{"nctId":"NCT06278727","phase":"","title":"Development and Validation of the Prediction Model for Functional Mitral Regurgitation Regression in Heart Failure Patients Taking Guideline-directed Medical Therapy","status":"UNKNOWN","sponsor":"Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University","startDate":"2024-01-01","conditions":["Mitral Regurgitation","Heart Failure"],"enrollment":270,"completionDate":"2025-12-31"},{"nctId":"NCT06192524","phase":"","title":"OPTImal PHARMacological Therapy for Patients With Heart Failure: The OPTIPHARM-HF Registry","status":"UNKNOWN","sponsor":"Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia","startDate":"2022-07-18","conditions":["Heart Failure"],"enrollment":2000,"completionDate":"2025-10-01"},{"nctId":"NCT03016975","phase":"NA","title":"Edwards Cardioband System ACTIVE Pivotal Clinical Trial (ACTIVE)","status":"TERMINATED","sponsor":"Edwards Lifesciences","startDate":"2017-06-01","conditions":["Functional Mitral Regurgitation","Mitral Regurgitation","Mitral Insufficiency"],"enrollment":12,"completionDate":"2022-09-20"},{"nctId":"NCT06126081","phase":"NA","title":"Clinical Efficacy of Early Left Bundle Branch Pacing for Cardiac Resynchronization Therapy","status":"UNKNOWN","sponsor":"Fu Wai Hospital, Beijing, China","startDate":"2023-06-26","conditions":["Heart Failure","Left Bundle Branch Pacing"],"enrollment":36,"completionDate":"2025-12-30"},{"nctId":"NCT06102031","phase":"NA","title":"Clinical Study on the Noninvasive Lung Fluid Monitoring System in Guiding the Treatment of Heart Failure","status":"NOT_YET_RECRUITING","sponsor":"Shanghai Zhongshan Hospital","startDate":"2023-11","conditions":["Heart Failure"],"enrollment":1000,"completionDate":"2026-12"},{"nctId":"NCT05170165","phase":"","title":"A Pilot Study to Increase Utilization of GDMT in Patients With HFrEF","status":"UNKNOWN","sponsor":"Cedars-Sinai Medical Center","startDate":"2022-01-12","conditions":["Heart Failure"],"enrollment":50,"completionDate":"2023-09-25"},{"nctId":"NCT05212649","phase":"","title":"Optimized Peak VO2 in Predicting Advanced HF","status":"COMPLETED","sponsor":"Chang Gung Memorial Hospital","startDate":"2014-05-01","conditions":["Heart Failure","Morality","Transplant; Failure, Heart"],"enrollment":377,"completionDate":"2021-07-30"}],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"formularyStatus":[],"_enricherVersion":"v2-openfda","developmentCodes":[],"ownershipHistory":[{"period":"","companyName":"Fu Wai Hospital, Beijing, China","relationship":"Original Developer"}],"publicationCount":1066,"therapeuticAreas":["Other"],"biosimilarFilings":[],"originalDeveloper":"Fu Wai Hospital, Beijing, China","recentPublications":[{"date":"2026 Mar","pmid":"41906611","title":"Heart Failure Therapy Improves Outcomes in Adults With Congenital Heart Disease and Left Ventricular Dysfunction.","journal":"JACC. Advances"},{"date":"2026 Mar 29","pmid":"41904956","title":"Heart failure outcomes in a virtually run hospital-at-home setting.","journal":"European heart journal. Quality of care & clinical outcomes"},{"date":"2026 Mar 26","pmid":"41903581","title":"Guideline-directed medical therapy and hypotension after initiation of Vericiguat: Insights from the VERIFY-HF study.","journal":"Journal of cardiology"},{"date":"2026 Mar 11","pmid":"41899053","title":"Two-Year Implementation, Adherence, and Outcomes of Quadruple Guideline-Directed Medical Therapy in Newly Diagnosed HFrEF: Insights from the Prospective CaRD Registry.","journal":"Journal of clinical medicine"},{"date":"2026 Apr","pmid":"41891318","title":"Standardizing the Clinical Approach to Cancer Therapy-Related Cardiac Dysfunction: Applying Cardio-Oncology Guidelines as a Practical Tool for Hematology and Oncology Providers.","journal":"Cancer medicine"}],"companionDiagnostics":[],"genericManufacturerList":[],"status":"active","brandName":"GDMT","companyName":"Fu Wai Hospital, Beijing, China","companyId":"fu-wai-hospital-beijing-china","modality":"Small molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":3,"visitCount":1,"regulatoryByCountry":[{"country_code":"CA","regulator":"Health Canada","status":"approved","approval_date":null,"mah":"","brand_name_local":"","application_number":""},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":31,"withResults":0},"validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T00:57:41.419365+00:00","fieldsConflicting":1,"overallConfidence":0.8},"verificationStatus":"enriching","dataCompleteness":{"mechanism":false,"indications":false,"safety":false,"trials":true,"score":1}}